- Home
- ASM vs CBLL Comparison
ASM vs CBLL Comparison
Compare ASM & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASM | CBLL |
|---|---|---|
| Founded | 1968 | 2014 |
| Country | Canada | United States |
| Employees | N/A | 280 |
| Industry | Metal Mining | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.7M | 750.1M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASM | CBLL |
|---|---|---|
| Price | $6.88 | $18.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $8.18 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 4.2M | 290.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.91 | $29.57 |
| Revenue Next Year | $62.02 | $28.44 |
| P/E Ratio | $67.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.37 | $10.01 |
| 52 Week High | $11.99 | $24.33 |
Technical Indicators
Market Signals| Indicator | ASM | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 42.28 |
| Support Level | $3.70 | $16.69 |
| Resistance Level | $9.70 | $22.49 |
| Average True Range (ATR) | 0.56 | 0.81 |
| MACD | -0.25 | 0.05 |
| Stochastic Oscillator | 0.69 | 51.08 |
Price Performance
Historical ComparisonAbout ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.